Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech discovers new cytokine inducing apoptosis

Sep. 17, 1997

Pharmacia & Upjohn discovers potent camptothecin analogues

Sep. 17, 1997

Preliminary results from phase II/III Sensamide study

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

Cytel and Searle to collaborate on cancer therapies

Sep. 15, 1997

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Clinical studies begin with BNP-7787

Sep. 12, 1997

Final phase I/IIa data reported on oral Panretin in APL

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...